| EARNINGS PER SHARE |
14 - EARNINGS PER SHARE The computation of basic and dilutive net loss per share attributable to common stockholders for the three and nine months ended September 30, 2026 and 2025, are as follows: | | | Three Months Ended September 30, | | | Nine Months Ended September 30, | | | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | Basic: | | | | | | | | | | | | | | Numerator: | | | | | | | | | | | | | | Net income (loss) attributable to common shareholders | | $ | (3,659,587 | ) | | $ | 1,375,294 | | | $ | (12,358,543 | ) | | $ | (1,736,512 | ) | | Denominator: | | | | | | | | | | | | | | | | | | Weighted-average common shares outstanding | | | 2,981,011 | | | | 2,282,245 | | | | 2,703,046 | | | | 2,016,265 | | | Net income (loss) per share – basic: | | $ | (1.16 | ) | | $ | 0.60 | | | $ | (4.47 | ) | | $ | (0.86 | ) | | Diluted: | | | | | | | | | | | | | | | | | | Numerator: | | | | | | | | | | | | | | | | | | Net income (loss) attributable to common and common equivalent shareholders | | | (3,659,587 | ) | | | 1,375,294 | | | | (12,358,543 | ) | | | (1,736,512 | ) | | Denominator: | | | | | | | | | | | | | | | | | | Weighted-average common stock outstanding | | | 3,168,308 | | | | 2,282,245 | | | | 2,766,165 | | | | 2,016,265 | | | Stock options, RSUs, warrants, Earn-Out Liability, and convertible notes outstanding to purchase shares of common stock | | | - | | | | 1,274 | | | | - | | | | - | | | Total common and common equivalent shares outstanding | | | 3,168,308 | | | | 2,283,520 | | | | 2,766,165 | | | | 2,016,265 | | | Net income (loss) per share – diluted: | | $ | (1.16 | ) | | $ | 0.60 | | | $ | (4.47 | ) | | $ | (0.86 | ) | The weighted average potential shares of common stock that were excluded from the calculation of net loss per share-diluted for the periods presented because including them would have been anti-dilutive consisted of the following: | | | Three Months Ended September 30, | | | Nine Months Ended September 30, | | | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | Stock options outstanding to purchase shares of common stock and RSUs | | | 415,577 | | | | 222,684 | | | | 395,249 | | | | 214,974 | | | Public Warrants | | | 319,216 | | | | 319,216 | | | | 319,216 | | | | 319,216 | | | SPAC Private Placement Warrants | | | 262,811 | | | | 262,811 | | | | 262,811 | | | | 262,811 | | | Private Veea Warrants | | | 7,965 | | | | 7,965 | | | | 7,965 | | | | 7,965 | | | 2025 Investor Warrants | | | 459,305 | | | | 234,721 | | | | 459,305 | | | | 79,100 | | | Convertible Notes | | | 282,729 | | | | 11,667 | | | | 280,943 | | | | 6,964 | | | White Lion Warrants | | | 130,103 | | | | - | | | | 105,646 | | | | - | | | NLabs Warrants | | | 2,344,173 | | | | - | | | | 1,379,813 | | | | - | | The weighted average potential shares of common stock that were excluded from the calculation of net loss per share-diluted because the performance or market conditions associated with these awards were not met are as follows for the periods presented: | | | Three Months Ended September 30, | | | Nine Months Ended September 30, | | | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | Earn-Out Liability | | | 225,000 | | | | 225,000 | | | | 225,000 | | | | 225,000 | |
|